Bimzelx 320 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FXB95
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,341
Award facts
- Contract value 100% obligated
- $25,341.44 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,341.44 to AmerisourceBergen Drug Corp for the supply of BIMZELX 320 mg/2 ml syringes. The contract, issued on August 29, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of September 2, 2025, and represents a non-competitive set-aside award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. BIMZELX is a prescription medication used in the treatment of plaque psoriasis and psoriatic arthritis, making this delivery critical for military and federal healthcare system pharmaceutical supply chains.
This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support Defense Health Agency operations and other federal healthcare systems worldwide. The company's established IDC structure enables efficient fulfillment of specialized pharmaceutical requirements such as this BIMZELX order, demonstrating the vendor's critical role in sustaining military medical readiness and healthcare operations across the Department of Defense enterprise.
Quick answers
Who was awarded contract SPE2DB25FXB95?
SPE2DB25FXB95 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FXB95 worth?
The government has obligated $25,341 on SPE2DB25FXB95.
Is contract SPE2DB25FXB95 an order under another contract?
Yes. SPE2DB25FXB95 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXB95 competed?
The extent of competition for SPE2DB25FXB95 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award